Qube Research & Technologies LTD Capricor Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$4.63 - $7.09 $254,511 - $389,737	-54,970 Reduced 79.2%	14,433 $68,000
Q1 2024 May 14, 2024	BUY	$3.61 - $6.88 $51,962 - $99,030	14,394 Added 26.17%	69,403 $471,000
Q4 2023 Feb 13, 2024	BUY	$2.71 - $5.08 $133,819 - $250,850	49,380 Added 877.24%	55,009 $268,000
Q3 2023 Nov 13, 2023	BUY	$3.42 - $7.85 $19,251 - $44,187	5,629 New	5,629 $19,000

8.13M

1.78M

1.4M

Ticker CAPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,346,200
Market Cap $318M
Description
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.